News Snapshot:
WHO vaccine experts said Wednesday that an interim analysis of clinical trial data from two Chinese Covid-19 vaccines showed they demonstrated "safety and good efficacy", but that more data was needed. The Chinese firms Sinovac and Sinopharm, whose Covid jabs are already being used in several countries, have submitted data in applications for the World Health Organization's emergency use listing (EUL) green light. The UN health agency's Strategic Advisory Group of Experts on Immunization (SAGE) said it had reviewed the data provided so far, and that both vaccines "demonstrated safety and good efficacy against symptomatic Covid-19 disease". However, it warned,...
